Live Breaking News & Updates on Sternir Inc

Stay updated with breaking news from Sternir inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson's Disease and Provides Update on Ongoing Enrollment -October 16, 2023 at 07:02 am EDT

BOSTON and ATLANTA, Oct. 16, 2023 Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s. ....

United States , Alex Lobo , Miltonh Werner , Milton Werner , Sternir Inc , Inhibikase Or Company , Exchange Commission , Company Contact , Inhibikase Therapeutics Inc , Movement Disorders Society Congress , Abelson Tyrosine Kinases , Movement Disorders Society , England Activities , Daily Life Scale , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy

Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Miltonh Werner , Milton Werner , Alex Lobo , Sternir Inc , Movement Disorder Society Congress , Exchange Commission , Inhibikase Or Company , Drug Administration , Company Contact , Inhibikase Therapeutics Inc , Drug Designation , Multiple System , Abelson Tyrosine Kinases , Orphan Drug Designation , Multiple System Atrophy , Chief Executive , System Atrophy , Abelson Tyrosine Kinase , Abelson Tyrosine , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity

Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Miltonh Werner , Alex Lobo , Sternir Inc , Inhibikase Or Company , Exchange Commission , Company Contact , Movement Disorder Society , Inhibikase Therapeutics Inc , Therapeutics Issues , Recent Trading , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Chronic Myelogenous Leukemia , Multiple System Atrophy , Clinical Hold , Stable Phase Chronic Myelogenous , Abelson Tyrosine Kinase , Ableson Tyrosine , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Issues a Letter to Shareholders and

BOSTON and ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage. ....

United States , Miltonh Werner , Alex Lobo , Inhibikase Or Company , Company Contact , Sternir Inc , Movement Disorder Society , Inhibikase Therapeutics Inc , Exchange Commission , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Chronic Myelogenous Leukemia , Multiple System Atrophy , Clinical Hold , Stable Phase Chronic Myelogenous , Abelson Tyrosine Kinase , Ableson Tyrosine , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib

- New tablet formulation of risvodetinib approximately doubles drug exposure at same dose –
- Tablet formulation to be evaluated in the planned 12-month extension portion of the 201. ....

United States , Miltonh Werner , Milton Werner , Alex Lobo , Exchange Commission , Inhibikase Or Company , Sternir Inc , Inhibikase Therapeutics Inc , Company Contact , Inhibikase Therapeutics , Abelson Tyrosine Kinases , Abelson Tyrosine Kinase , Ableson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act ,